EUVIMEDEUVIMED entdecken
Leitlinie

An analysis of Russian-produced clinical practice guidelines using the RIGHT reporting checklist: The case of direct oral anticoagulants for coronavirus disease 2019

Elena A Baybulatova iD, Mikhail S Chenkurov iD, Elina A Korovyakova iD, Sergey K Zyryanov iD, Dmitry A Sychev iD, Irina V Poddubnaya iD, Yaolong Chen iD, Janne Estill iD, Liliya E Ziganshina iD

International Journal of Risk & Safety in Medicine · 2026

DOI: 10.1177/09246479251375246 ↗

Kurz gefasst

Leitlinie in der Zeitschrift International Journal of Risk & Safety in Medicine, 2026. Verfasst von Elena A Baybulatova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Рeoples' Friendship University of Russia Named After Patrice Lumumba (RUDN University), Moscow, Russia. Hauptthemen laut MEDLINE: Checklist, Anticoagulants, Practice Guidelines as Topic, COVID-19 Drug Treatment. Die Arbeit nennt 14 Literaturangaben. Gefördert von: Peoples’ Friendship University of Russia named after Patrice Lumumba.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of the study was to compare the results of quality assessment of Russian-produced clinical practice guidelines on the use of direct oral anticoagulants in the treatment and prophylaxis of coronavirus disease 2019 using the RIGHT checklist and AGREE II instrument.

Methods

We assessed six relevant clinical practice guidelines published between 2020 and 2023 in Russian databases using the RIGHT checklist. We compared the results of using the RIGHT tool with the results obtained using the AGREE II instrument.

Results

All six clinical guidelines received high scores in the sections “Basic information” (range: 56.2%–70.8%) and “Background” (48.4%–74.0%). The lowest results were obtained in the sections on RIGHT: “Review and quality assurance” (0%–4.2%) and “Funding and declaration management of interests” (14.6%–19.8%).

Conclusion

The RIGHT checklist was proven applicable and usable for evaluating Russian-produced clinical practice guidelines. The use of RIGHT reporting tool enriched the depth and breadth of quality assessment to identify more areas that are problematic and to critically appraise details of the problems. More efforts are needed to further improve Russian clinical practice guidelines and their implementation into clinical practice to ensure better patient care and rational use of direct oral anticoagulants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChecklistAnticoagulantsPractice Guidelines as TopicCOVID-19 Drug TreatmentHumansRussiaAdministration, OralCOVID-19SARS-CoV-2

Stichwörter der Autor:innen

AGREE IICOVID-19DOACsRIGHTclinical practice guidelinesquality assessment

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Рeoples' Friendship University of Russia Named After Patrice Lumumba (RUDN University), Moscow, Russia.
  • State Budgetary Institution of Healthcare of the City of Moscow "City Clinical Hospital No. 24 of the Moscow City Health Department", Russia.
  • Cochrane Russia at the Russian Medical Academy for Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • School of Basic Medical Sciences, Lanzhou University, China.
  • Research Unit of Evidence Based Evaluation and Guidelines, Chinese Academy of Medical Sciences (2021RU017), Lanzhou University, China.
  • WHO Collaborating Centre for Guideline Implementation and Knowledge Translation, Lanzhou, China.

ORCID-Profile: Elena A Baybulatova, Mikhail S Chenkurov, Elina A Korovyakova, Sergey K Zyryanov, Dmitry A Sychev, Irina V Poddubnaya, Yaolong Chen, Janne Estill, Liliya E Ziganshina

Förderung

  • Peoples’ Friendship University of Russia named after Patrice Lumumba

Zitieren

APA

Baybulatova, E. A., Chenkurov, M. S., Korovyakova, E. A., Zyryanov, S. K., Sychev, D. A., Poddubnaya, I. V., Chen, Y., Estill, J., & Ziganshina, L. E. (2026). An analysis of Russian-produced clinical practice guidelines using the RIGHT reporting checklist: The case of direct oral anticoagulants for coronavirus disease 2019. International Journal of Risk & Safety in Medicine. https://doi.org/10.1177/09246479251375246

Vancouver

Baybulatova EA, Chenkurov MS, Korovyakova EA, Zyryanov SK, Sychev DA, Poddubnaya IV, et al. An analysis of Russian-produced clinical practice guidelines using the RIGHT reporting checklist: The case of direct oral anticoagulants for coronavirus disease 2019. International Journal of Risk & Safety in Medicine. 2026. doi:10.1177/09246479251375246

BibTeX
@article{Baybulatova2026,
  author = {Baybulatova, Elena A and Chenkurov, Mikhail S and Korovyakova, Elina A and Zyryanov, Sergey K and Sychev, Dmitry A and Poddubnaya, Irina V and Chen, Yaolong and Estill, Janne and Ziganshina, Liliya E},
  title = {An analysis of Russian-produced clinical practice guidelines using the RIGHT reporting checklist: The case of direct oral anticoagulants for coronavirus disease 2019},
  journal = {International Journal of Risk & Safety in Medicine},
  year = {2026},
  doi = {10.1177/09246479251375246}
}
Kostenlos starten →